GLP-1 Receptor Agonists and Body Composition: What Research Really Shows About Muscle Loss

The weight loss results from GLP-1 receptor agonists are undeniable. A landmark 2021 study in The New England Journal of Medicine showed semaglutide users lost 14.9% of body weight over 68 weeks—compared to just 2.4% with placebo and lifestyle changes alone. That’s transformative for men struggling with obesity.

But here’s what many men don’t ask: What kind of weight are you actually losing?

This is where the conversation gets more nuanced. Recent research reveals that while GLP-1 medications are exceptionally effective at reducing total body weight, their impact on lean muscle mass—one of the most important markers of long-term health and metabolic resilience—tells a more complex story than the headlines suggest.

If you’re considering GLP-1 therapy, already using it, or simply trying to understand modern weight loss science, this research-backed breakdown will show you what’s actually happening inside your body and how to optimize your approach.

How Much Lean Mass Do You Actually Lose on GLP-1s?

A 2025 systematic review and network meta-analysis published in Metabolism: Clinical and Experimental provides the clearest answer yet. Researchers analyzed 22 randomized controlled trials involving 2,258 participants to determine exactly how GLP-1 medications affect body composition.

Here’s what they found:

• Total weight loss: 3.55 kg reduction (vs. placebo)
• Fat mass loss: 2.95 kg reduction—the primary goal
• Lean mass loss: 0.86 kg reduction—approximately 25% of total weight lost

Translation: For every kilogram of weight you lose on GLP-1s, about 250 grams of that is lean tissue—not ideal, but not catastrophic either.

The critical nuance here is this: lean mass includes muscle, bone, organs, and water. When researchers analyzed studies using more precise imaging (like MRI), the picture shifted. A 2024 Circulation review by leading metabolic experts concluded that skeletal muscle changes with GLP-1 treatments appear to be “adaptive”—meaning the muscle loss is proportional to the weight loss achieved and what you’d expect from aging and weight reduction alone.

In other words: you’re not losing excessive muscle. You’re losing fat, with muscle loss that tracks normally with the weight reduction.

Which GLP-1s Preserve Muscle Best (and Which Don’t)?

Not all GLP-1 receptor agonists perform equally when it comes to body composition. The 2025 meta-analysis revealed striking differences:

Best for muscle preservation:

• Liraglutide (3.0 mg weekly or 1.8 mg daily) was the only GLP-1RA in the analysis to achieve significant weight reduction without significantly reducing lean mass

Most potent overall, but greater lean mass reduction:

• Tirzepatide (15 mg weekly)—superior fat loss but among the least effective at preserving lean mass
• Semaglutide (2.4 mg weekly)—greatest weight and fat mass reduction but similarly associated with greater lean mass loss

Why the difference? The research indicates it’s partly due to “drug-specific and molecular effects,” plus differences in how aggressively each medication suppresses appetite and reduces total calorie intake. More aggressive weight loss naturally leads to slightly more lean mass loss unless mitigated by resistance training and adequate protein.

For men prioritizing muscle preservation while losing fat: liraglutide may offer a better balance, though it produces more modest overall weight loss than semaglutide or tirzepatide.

Muscle Loss Is Adaptive—If You Train and Eat Right

Here’s the reassuring part of recent research: the muscle loss observed with GLP-1s isn’t necessarily harmful or unexpected.

A 2024 review in Diabetes, Obesity & Metabolism emphasizes that “skeletal muscle changes with GLP-1RA treatments appear to be adaptive” when studied with advanced imaging techniques. The authors note that:

• Reductions in muscle volume are commensurate with what’s expected given aging, disease status, and total weight loss
• Improvements in insulin sensitivity and reduced muscle fat infiltration suggest improved muscle quality, not just size
• The probability of losing strength and function is lowered when appropriate lifestyle measures are implemented

The key phrase: improved muscle quality. You might lose 1-2 kg of lean mass, but the muscle that remains is cleaner, more insulin-sensitive, and functionally better.

What this means for your approach:

• Resistance training is non-negotiable. Progressive strength work preserves muscle fiber and prevents the adaptive response from becoming detrimental
• Protein intake must be prioritized. With reduced appetite from GLP-1s, it’s easy to under-eat protein. Aim for 1.6-2.2 g per kg of body weight
• Don’t fear the initial lean mass loss. If you’re training and eating adequate protein, the muscle loss will be minimal and the fat loss will be substantial

Nutritional and Lifestyle Strategies to Maximize Body Composition

In 2025, a joint advisory from the American College of Lifestyle Medicine, American Society for Nutrition, Obesity Medicine Association, and The Obesity Society provided comprehensive guidance. Their research review emphasized that “evidence-based nutritional and lifestyle strategies play a pivotal role” in optimizing GLP-1 treatment outcomes—and these strategies apply broadly to any weight loss approach.

Before starting (or during) any weight loss protocol):

• Get a baseline body composition assessment. DEXA scan, InBody, or even good calipers let you track whether you’re losing fat or muscle
• Assess muscle strength and function. Can you perform 10 push-ups? How’s your grip strength? These matter more than scale weight
• Screen for nutritional deficiency risk. Rapid weight loss increases risk of vitamin B12, iron, calcium, and vitamin D insufficiency

During weight loss (whether with GLP-1s or not):

• Prioritize protein at every meal. Aim for 30-40g per meal minimum. This preserves muscle and maintains satiety
• Resistance train 3-4x weekly. Focus on compound movements (squats, deadlifts, presses, rows). This is the single strongest stimulus to preserve muscle during weight loss
• Manage gastrointestinal side effects nutritionally. If using GLP-1s, smaller, frequent high-protein meals help with nausea and ensure adequate intake
• Monitor micronutrient status. Consider supplementing vitamin B12 (if on GLP-1s), vitamin D, and potentially magnesium and calcium
• Don’t create massive calorie deficits. Aggressive undereating accelerates lean mass loss. A moderate 500 kcal/day deficit is more sustainable and preserves muscle better than extreme restriction

Post-weight loss:

• Maintain resistance training to defend your lean mass gains
• Continue adequate protein intake (1.6+ g/kg) even at weight maintenance
• Monitor for sarcopenia risk, especially if you’re over 50. The research notes that older age and prefrailty may require modified approaches to GLP-1 therapy

Who Should Be Cautious About Lean Mass Loss?

Recent research highlights that factors such as older age and pre-existing frailty may influence the selection of appropriate candidates for GLP-1 therapies due to sarcopenia risk.

If you fall into these categories, additional considerations apply:

• Men over 65: Baseline DEXA scan and strength testing are worthwhile. Even 2-3 kg of lean mass loss can impair independence if you’re already at lower baseline muscle mass
• Men with existing frailty or low physical activity: Start with lifestyle intervention and resistance training BEFORE adding GLP-1 therapy. Build a foundation first
• Men with significant comorbidities (advanced diabetes, heart disease): Work closely with your doctor. The metabolic benefits of weight loss often outweigh lean mass considerations, but personalization matters

Bottom Line: What This Research Means for You

The evidence is clear: GLP-1 receptor agonists are powerful tools for weight loss, and the lean mass loss they cause is adaptive and manageable—not catastrophic.

Here’s what to take away:

• You’ll lose approximately 25% of weight loss as lean mass (0.86 kg for every 3.55 kg weight loss), but this is proportional to overall weight loss and aging
• Muscle quality often improves even as volume decreases slightly, thanks to reduced inflammation and better insulin sensitivity
• Your intervention—resistance training, adequate protein, moderate calorie deficit—matters more than the medication itself
• Liraglutide preserves lean mass best; tirzepatide and semaglutide offer greater overall weight loss with slightly more lean mass impact
• Older men and those with prefrailty should approach weight loss more conservatively and prioritize strength training

Whether you use GLP-1s or not, the fundamentals remain the same: lift heavy things, eat enough protein, create a moderate calorie deficit, and prioritize sleep and stress management. The medication accelerates fat loss, but your behavior determines whether that loss is quality or not.

Next Steps

If you’re considering GLP-1 therapy, have an honest conversation with your doctor about your body composition goals and baseline muscle status. Request or seek out a DEXA scan or body composition assessment.

Regardless of your approach—GLP-1, traditional calorie restriction, or another method—start strength training today. It’s the most evidence-backed way to preserve and build muscle while losing fat.

Want to optimize your training and nutrition for maximum fat loss and muscle preservation? Explore our guides on strength training for fat loss, optimal protein intake for muscle building, and how to track body composition accurately.